21029 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4)
Sub-classes:BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES
#2METHODS AND COMPOSITIONS FOR TREATING CANCER
#3METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV
#4USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
#5METHOD FOR THE PRODUCTION OF AN ENZYMATIC COMPOSITION COMPRISING A RECOMBINANT ENDOPEPTIDASE
#6PROBIOTIC STRAINS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME AND FODMAP INTOLERANCE
#7METHODS FOR PROMOTING NERVE GROWTH
#8METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS
#9PRODUCTION OF 2-3-CYCLIC GMP-AMP (cGAMP) AND METHOD OF USE THEREOF
#10METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES
#11METHODS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS
#12BACILLUS VELEZENSIS COMPOSITIONS AND METHODS OF USE THEREOF
#13HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS
#14CYSTEINE PROTEASE
#15USE OF MUTANT OF IMMUNOGLOBULIN DEGRADING ENZYME IDEE
#16AGGREGATE FORMED BY MEANS OF ASSEMBLING CHALCOGEN HETEROCYCLIC COMPOUND AND INSULIN, AND PREPARATION METHOD THEREFOR, AND INSULIN ORAL PREPARATION
#17HOLLOW MULTILAYER METAL-ORGANIC-FRAMEWORK MATERIAL AND PREPARATION METHOD AND APPLICATION THEREOF
#18USE OF HEMATOPOIETIC CELL KINASE (HCK) INHIBITOR IN PREPARATION OF DRUG FOR TREATING PULMONARY FIBROSIS
#19USE OF Galectin-1 INHIBITOR IN PREPARATION OF DRUG FOR TREATING PULMONARY FIBROSIS
#20CONJUGATES WITH INHIBITORY RECEPTOR LIGANDS TO INDUCE ANERGY IN INSULIN-BINDING B CELLS
#21SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF
#22SUPPLEMENT COMPOSITION FOR CONSUMPTION BY INDIVIDUALS BEING ADMINISTERED A GLP-1 AGONIST
#23COMPOSITIONS FOR GUT HEALTH
#24PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE
#25PAPN MUTANT, METHOD FOR SITE-DIRECTED MODIFICATION OF PAPN GENE AND USE THEREOF
#26DEVICES AND METHODS FOR THE PREPARATION OF A NUTRITIONAL FORMULA
#27BACILLUS VELEZENSIS COMPOSITIONS AND METHODS OF USE THEREOF
#28USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION
#29Use of mutant of immunoglobulin degrading enzyme IdeE
#30USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
#31NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#32COMPOSITIONS AND METHODS FOR DEBULKING VIRUS OR MICROORGANISM LOAD IN THE ORAL CAVITY
#33Conjugates with inhibitory receptor ligands to induce anergy in insulin-binding B cells
#34USE OF CLOSTRIDIUM HISTOLYTICUM PROTEASE MIXTURE IN PROMOTING WOUND HEALING
#35NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#36ACE2 FUSION PROTEINS AND USES THEREOF
#37METHODS OF TREATING CELIAC DISEASE
#38CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#39METHODS AND COMPOSITIONS FOR IMPROVING PROTEIN HYDROLYSIS
#40Compositions and Methods for Treating Celiac Sprue Disease
#41METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER
#42USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
#43CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#44METHODS AND COMPOSITIONS FOR IMPROVING PROTEIN HYDROLYSIS
#45METHODS FOR REDUCING PATHOGENIC E COLI BY SELECTIVE FEED ADDITIVE INTERVENTION COMPRISING ENZYMES SUCH AS MURAMIDASE
#46VARIANT IGF2 CONSTRUCTS
#47Compositions Comprising Nucleic Acid Molecules and Methods of Treating ATPase-Mediated Diseases
#48METHODS OF TREATMENT FOR FUNCTIONAL DECLINE IN HIPPOCAMPUS, FOR IMPROVING RECOGNITION MEMORY ACCURACY, AND FOR IMPROVING HIPPOCAMPAL NEURONAL FUNCTION
#49AVIAN FOOD ADDITIVE
#50RESPIRABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING A POLYPEPTIDE FOR CORONA VIRUS TREATMENT AND NEUTRALIZATION
#51PARAPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITION ADMINISTRABLE TO A LIVING BEING, PREFERABLY A HUMAN BEING, COMPRISING AT LEAST ONE ENZYME FOR THE TREATMENT AND/OR PREVENTION OF BACTERIAL INFECTIONS INVOLVING BIOFILM FORMATION
#52CYSTEINE PROTEASE
#53Non-protein Clostridial toxin compositions
#54Non-protein clostridial toxin compositions
#55COMPOSITION FOR IMPROVING DIAGNOSTIC ACCURACY FOR USE IN MAGNIFYING ENDOSCOPY AND ENDOCYTOSCOPY
#56CYSTEINE PROTEASE
#57METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
#58COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS
#59COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME
#60METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY
#61NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#62COMPOUND NUTRIENT CAPABLE OF REPAIRING DAMAGED INTESTINES OF PIGELETS AND METHOD OF USING THE SAME
#63PLASMINOGEN FOR USE IN TREATING AND PREVENTING LUNG DYSFUNCTION
#64COMBINED ANIMAL-DERIVED AND SYNTHETICALLY PRODUCED PANCREATIC ENZYME REPLACEMENT THERAPY
#65COMPOSITIONS AND METHODS FOR TREATING PANCREATIC ENZYME DEFICIENCIES IN MAMMALS
#66METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES
#67MEDICAL USE OF ICARITIN
#68IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLS
#69COMBINED MULTISTAGE MICROBIAL PREPARATIONS AND METHOD OF THEIR APPLICATION
#70BACTERIAL TOXINS AND USES THEREOF AS RAS SPECIFIC PROTEASES FOR TREATING CELL PROLIFERATION DISEASES AND DISORDERS
#71KIT FOR PREPARING DISEASE-TREATING AGENT, DISEASE-TREATING AGENT AND METHOD FOR PREPARING DISEASE-TREATING AGENT
#72METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)
#73DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT
#74Compositions for gut health
#75METHOD FOR THE PRODUCTION OF AN ENZYMATIC COMPOSITION COMPRISING A RECOMBINANT ENDOPEPTIDASE
#76GINGER DERIVED EXTRACELLULAR VESICLES AND USE THEREOF
#77METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV
#78ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE
#79ANTIMICROBIAL NANOWORMS
#80IMPROVED FIX FUSION PROTEIN AND CONJUGATE AND USE THEREOF
#81DIETARY SUPPLEMENT TO PROMOTE GUT HEALTH
#82COMPOSITION, SYSTEM AND METHOD FOR TREATING SKIN
#83METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING AMINO ACID LEVEL
#84METHODS OF TREATING CELIAC DISEASE
#85Devices and methods for the preparation of a nutritional formula
#86ABHD5 AND PARTIAL HDAC4 FRAGMENTS AND VARIANTS AS A THERAPEUTIC APPROACH FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
#87Cysteine protease
#88MICROBIAL STRAINS FOR VIRUS INHIBITION
#89BRCA1 MODULATING COMPOUNDS, FORMULATIONS THEREOF, AND USES THEREOF
#90Engineered protease variants
#91Compositions comprising nucleic acid molecules and methods of treating ATPase-mediated diseases
#92Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
#93Modified L-asparaginase
#94Methods of treating chronic disorders with complement inhibitors
#95NOVEL LINKERS
#96Method for improving intestinal flora
#97Mitrecin A polypeptide with antimicrobial activity
#98Deimmunized lysostaphin and methods of use
#99BOTULINUM TOXIN ADMINISTRATION FOR TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY ASSOCIATED URINARY INCONTINENCE
#100Treatment of immune dysregulation disorders
#101USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
#102NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#103BORRELIA BURGDORFERI PEPTIDOGLYCAN AS A DIAGNOSTIC AND TARGET FOR THERAPEUTIC INTERVENTION OF LYME DISEASE-RELATED PATHOLOGIES
#104CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#105INHIBITION AND TREATMENT OF GASTROINTESTINAL BIOFILMS
#106METHODS AND COMPOSITIONS FOR TREATING CANCER
#107USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION
#108NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#109METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS
#110PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT USING SERRATIOPEPTIDASE, MANNOSE OR ITS DERIVATIVE, AND OPTIONALLY ANTINFECTION AGENTS
#111Compositions and methods for treating gluten intolerance and disorders arising therefrom
#112Targeting PAX2 for the treatment of breast cancer
#113METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS
#114Method of Treating a Disorder of Cognitive Performance or Memory
#115METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER
#116PAIN RESPONSE MEDIATOR COMPOSITIONS AND METHODS FOR MAKING AND USING SAME
#117Immobilized Enzyme Complexes and Related Methods
#118STAPHYLOCOCCAL COAGULASE ANTIGENS AND METHODS OF THEIR USE
#119Compositions and methods for treating gluten intolerance and disorders arising therefrom
#120BACTERIAL TOXINS AND USES THEREOF AS RAS SPECIFIC PROTEASES FOR TREATING CELL PROLIFERATION DISEASES AND DISORDERS
#121Compositions and Methods for Treating Celiac Sprue Disease
#122Composition comprising erigeron annuus flower essential oil for prevention and treatment of neuromuscular disease
#123CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#124Use of direct-fed microbials in preventing and/or treating -based infections in animals
#125Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor
#126Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor
#127USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY
#128TREATMENT OF LYSOSOMAL STORAGE DISEASE IN THE EYE THROUGH ADMINISTRATION OF AAVS EXPRESSING TPP1
#129Mitrecin A polypeptide with antimicrobial activity
#130Compositions and Methods for Safe Treatment of Rhinitis
#131Chimeric proteins and their use in identifying anti-deubiquitinase compounds
#132Adeno-associated virus virion for gene transfer to nervous system cells
#133METHODS AND COMPOSITIONS RELATED TO LONG HALF-LIFE COAGULATION COMPLEXES
#134Cysteine protease
#135Non-cellular root canal filling material and non-cellular dental tissue regeneration promoting kit
#136Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#137Combined Multistage Microbial Preparations and Method of Their Application
#138DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT
#139COMPOSITIONS AND METHODS FOR MONITORING PROGRESSION AND REGRESSION OF DISEASE IN PATIENTS IN RESPONSE TO THERAPY
#140PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY
#141VACCINIA VIRUS FOR GENE-DIRECTED ENZYME PRODRUG THERAPY
#142Cysteine protease
#143Stable Bioactive Substances and Methods of Making
#144METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)
#145TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#146Deimmunized lysostaphin and methods of use
#147LYPD1 INHIBITOR AND METHOD FOR PRODUCING BIOLOGICAL TISSUE USING SAME
#148Non-protein clostridial toxin compositions
#149METHOD FOR PREVENTING AND TREATING PATHOLOGICAL RENAL TISSUE INJURY
#150FACTOR X VARIANTS
#151Method for promoting insulin secretion
#152Method for making glucagon and insulin restore normal balance
#153Targeted enzymatic degradation of quorum-sensing peptides
#154Dental pretreatment material and dental tissue regeneration kit
#155Methods of treating celiac disease
#156PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN
#157IMMUNOGLOBULIN PROTEASES, COMPOSITIONS, AND USES THEREOF
#158CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#159Method for prevention or treatment of acute and chronic thrombosis
#160Pharmaceutical composition containing a mixture of proenzymes and enzymes
#161SITE-SPECIFIC MUTAGENESIS MODIFIED YEAST DIPEPTIDYL PEPTIDASE III
#162METHODS OF DIAGNOSIS ALZHEIMER'S DISEASE
#163HUMAN ASPARAGINASE LACKING GLUTAMINASE ACTIVITY
#164METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME
#165Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor
#166Hemostatic composition comprising cross-linked hyaluronic acid derivative matrix
#167Method of treatment of schizophreniform disorder
#168CELL MEMBRANE TRANSLOCATION OF REGULATED SNARE INHIBITORS, COMPOSITIONS THEREFOR, AND METHODS FOR TREATMENT OF DISEASE
#169Modified L-Asparaginase
#170Use of Acid Stable Proteases in Animal Feed, Preferably to Increase Performance of Cocc-Vaccinated Broiler Chickens
#171Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
#172BMP peptides and methods of use
#173PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE
#174Use of antiplatelet thrombolysin in the preparation of medicine for treating thrombotic thrombocytopenic purpura
#175Chimeric proteins and their use in identifying anti-deubiquitinase compounds
#176SELECTIVE CELL-DEATH-INDUCING BINARY ENZYME SYSTEM
#177Intestinal flora improvement agent
#178Method for preventing and treating angiocardiopathy
#179Compositions and methods for treating celiac sprue disease
#180Feed additive composition
#181Devices and methods for the preparation of a nutritional formula
#182Compositions and methods for treating gluten intolerance and disorders arising therefrom
#183Modified L-asparaginase
#184METHOD FOR DETECTING INFECTIOUS PARVOVIRUS IN PHARMACEUTICAL PREPARATIONS
#185Method for preventing or treating diabetic retinopathy
#186Enzyme delivery systems and methods of preparation and use
#187Mitrecin a polypeptide with antimicrobial activity
#188COMPOSITIONS AND METHODS FOR IMPROVING HEART FUNCTION AND TREATING HEART FAILURE
#189Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders
#190SUPPRESSION OF ITCH
#191Method for Treating Pervasive Development Disorders
#192Inhibition and treatment of gastrointestinal biofilms
#193ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases
#194Staphylococcal coagulase antigens and methods of their use
#195Medicine for treatment and/or prevention of ischemic diseases, method for improving angiogenesis-promoting activity of cells, or method for producing medicine
#196Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems
#197Combination of TAFIa inhibitor with plasminogen activator
#198Methods and compositions related to long half-life coagulation complexes
#199Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
#200BMP-4 PEPTIDES AND METHOD OF USE
#201Compositions and methods for treating celiac sprue disease
#202BMP-7 PEPTIDES AND METHODS OF USE
#203Method of diagnosing preeclampsia or pregnancy-induced hypertension
#204METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CELIAC DISEASE AND GLUTEN INTOLERANCE
#205Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#206Methods and Compositions for the Treatment of Symptoms of Complex Regional Pain Syndrome
#207Non-protein clostridial toxin compositions
#208Targeted enzymatic degradation of quorum-sensing peptides
#209Methods of treating dementia associated with Alzheimer's disease with protective protein/cathepsin A (PPCA)
#210Cysteine proteases
#211Cysteine protease
#212Treatment of diseases related to hyperactivity of the complement system
#213Use of protease mixture in promoting wound healing
#214COMPOSITIONS FOR IMPROVEMENT OF BRAIN FUNCTION
#215PHARMACEUTICAL PREPARATION AND METHOD OF ITS PRODUCTION AND USE
#216Compositions and methods for treating celiac sprue disease
#217PHARMACEUTICAL PREPARATIONS FOR ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND OTHER ASSOCIATED DISORDERS
#218Treatment of migraine headaches with presynaptic neurotoxin
#219Method for prophylaxis or treatment of erbb1 positive cancers using a variant peptidase d with reduced activity
#220Compositions and methods for treating gluten intolerance and disorders arising therefrom
#221Method of treatment of schizophreniform disorder
#222Mitrecin a polypeptide with antimicrobial activity
#223Treatment and prophylaxis for lupus
#224Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
#225METHOD FOR TREATING PERVASIVE DEVELOPMENT DISORDERS
#226Deimmunized lysostaphin and methods of use
#227Method for improving the nutritional value of animal feed
#228Delivery of therapeutic agents by a collagen binding protein
#229PHARMACEUTICAL COMPOSITION AGAINST CHRONIC BACTERIAL INFECTIONS
#230Reduction of Lipoma Tissue
#231Cell Membrane Translocation of Regulated Snare Inhibitors, Compositions Therefor, and Methods for Treatment of Disease
#232Degradation of Beta-Amyloid Proteins With Keratinase
#233A Method for Improving Maize Digestibility in Bovine Animals
#234Compositions for Relieving the Symptoms of Gluten Sensitivity and Methods of Use Thereof
#235Non-cytotoxic protein conjugates
#236Antibacterial phage, phage peptides and methods of use thereof
#237Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use
#238Methods for treating cancer by administration of nucleic acids encoding FAP and cancer antigens
#239Method of treating proteinuria in pregnancy
#240COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME
#241Pharmaceutical preparation and method of its production and use
#242Use of Acid Stable Proteases in Animal Feed, Preferably to Increase Performance of COCC-Vaccinated Broiler Chickens
#243Use of angiotensin II (AII) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
#244Compositions and methods for safe treatment of rhinitis
#245Formulation for oral administration of proteins
#246Methods and compositions for the treatment of symptoms of Williams Syndrome
#247Compositions and methods for treating celiac sprue disease
#248Enzyme formulation for use as food supplement
#249Method of treating gluten intolerance by means of new S8/S53 endopetidases from the actinomycete
#250ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases
#251CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#252IS100- A Highly Effective Enzyme Principle For Use In Dermal Therapeutics, And For Health And Beauty
#253PANCREATIC ENZYME COMPOSITIONS AND METHODS FOR TREATING PANCREATITIS AND PANCREATIC INSUFFICIENCY
#254Enzyme delivery systems and methods of preparation and use
#255BACTERIAL TOXINS AND USES THEREOF AS RAS SPECIFIC PROTEASES
#256COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM
#257Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light
#258Targeted enzymatic degradation of quorum-sensing peptides
#259Treatment of diseases related to hyperactivity of the complement system
#260Intravitreal Injection of a Chimeric Phage Endolysin Ply187; Protection from Staphylococcus aureus Endophthalmitis
#261Enzyme delivery systems and methods of preparation and use
#262PROTEASE COMPOSITIONS FOR THE TREATMENT OF DAMAGED TISSUE
#263Compositions for improvement of brain function
#264Staphylococcal coagulase antigens and methods of their use
#265Treatment of Migraine Headaches with Presynaptic Neurotoxin
#266Lipase variants for pharmaceutical use
#267Compositions and methods for preventing cardiac arrhythmia
#268Method of treating pregnancy-induced hypertension
#269Exfoliative hair retention-promoting formulation
#270Compositions and methods for preventing cardiac arrhythmia
#271Enzyme delivery systems and methods of preparation and use
#272Mycotoxin-reducing composition
#273Method of treatment of schizophreniform disorder
#274Compositions and methods for reducing the incidence of equine digestive disorders
#275Polypeptide mixes with antibacterial activity
#276Marketing the use of an acidic soft drink to enhance the efficacy of a gluten-digesting enzyme
#277Methods for extracting a tooth
#278Delivery of therapeutic agents by a collagen binding protein
#279Methods and compositions for improving growth of meat-type poultry
#280POLYSACCHARIDE-PROTEIN CONJUGATES REVERSIBLY COUPLED VIA IMINE BONDS
#281Factor XII inhibitors for the treatment of neurological inflammatory disorders
#282METHODS AND COMPOSITIONS TO DETECT THE LEVEL OF LYSOSOMAL EXOCYTOSIS ACTIVITY AND METHODS OF USE
#283Sterilized and decellularized extracellular matrix for treating cardiac arrhythmia
#284New Proteases Able to Hydrolyze Gluten Peptides and Proteins at Acidic PH, from the Actinomycete Actinoallomurus
#285Proteases for degrading gluten
#286Triple Acting Antimicrobials That Are Refractory To Resistance Development
#287Non-cytotoxic protein conjugates
#288PANCREATIC ENZYME COMPOSITIONS AND METHODS FOR TREATING PANCREATITIS AND PANCREATIC INSUFFICIENCY
#289METHODS FOR IMPROVING GUT HEALTH
#290FEED ADDITIVE COMPOSITION
#291Stomatological composition
#292Cell therapy for the treatment of neurodegeneration
#293DRY POWDER FORMULATIONS OF ORGANIC MACROMOLECULES
#294Methods of treating alzheimer's disease by administration of protective protein/cathepsin A
#295Clostridial neurotoxins with altered persistency
#296Compositions and methods for treating celiac sprue disease
#297Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy
#298Compositions and methods for enhancing recovery after surgery or an athletic performance
#299Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems
#300MICROPELLET COMPOSITIONS COMPRISING PANCREATIN CONTAINING DIGESTIVE ENZYME MIXTURE